2023 Oncology Rehabilitation: Applying the Current Evidence

2023 Oncology Rehabilitation: Applying the Current Evidence

 January 14, 2023 

Jacksonville, Florida, United States

The American Cancer Society estimates there are currently 16 million Americans who are cancer survivors. Because of improved detection and treatment, nearly 70% of patients with a cancer diagnosis will go on to live their full life expectancy. Cancer treatments however are not without peril as the side effects of surgery; chemotherapy and radiotherapy have a deleterious impact on function in a majority of patients. These side effects may occur in both the short and long term and many persist over the remaining lifetime of the patient. With escalating numbers of survivors, we also see escalating functional limitations and disability in the survivorship population necessitating a greater focus on cancer by the rehabilitation community.

Asynchronous portion will be delivered in short video modules that will be in total duration of 180 minutes and will include the following content: Cancer Epidemiology, Tumor pathology, growth & histology, Disease diagnosis & staging, Disease treatment: surgery, chemotherapy, radiation therapy, hormonal therapy, immunotherapies. To be viewed prior to synchronous virtual course.

Read on eventbrite.com

Continue reading at

Related Offerings

Interested in this event?

Next Event

  • January

    UCSF Body Imaging: Abdominal and Thoracic

     January 15 to January 20, 2023 

    Fairmont Orchid - Hawaii, 1 North Kaniku Drive, Waimea, Hawaii, 96743, United States

    UCSF Body Imaging: Abdominal and Thoracic

Medigy Innovation Network

Connecting innovation decision makers to authoritative information, institutions, people and insights.

Medigy Logo

The latest News, Insights & Events

Medigy accurately delivers healthcare and technology information, news and insight from around the world.

The best products, services & solutions

Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.

© 2023 Netspective Media LLC. All Rights Reserved.

Built on Mar 31, 2023 at 1:19pm